Table 1 Demographic and clinical characteristics of the sample.
Total | Early PD | Advanced PD | |
|---|---|---|---|
N (female/male) | 22 (11/11) | 15 (8/7) | 7 (3/4) |
Age (years) | 65.8 ± 9.1 [42–81] | 65.2 ± 7.2 [52–77] | 67.1 ± 12.9 [42–81] |
Age of onset (years) | 59.5 ± 8.1 [47–75] | 60.1 ± 6.6 [51–75] | 55.1 ± 13.9 [36–75] |
Disease duration (years) | 8.9 ± 5.3 [2–19] | 6.0 ± 3.6 [2–13] | 13.0 ± 5.6 [7–19] |
MDS-UPDRS – Part I1 | 10.9 ± 6.0 [2–26] | 11.0 ± 6.9 [2–26] | 10.7 ± 4.6 [3.5–15.8] |
MDS-UPDRS – Part II1 | 14.7 ± 9.6 [2–43] | 11.9 ± 7.7 [2–24.3] | 19.3 ± 11.3 [9.7–43] |
MDS-UPDRS – Part III1 | 39.9 ± 16.8 [10–76.9] | 32.9 ± 12.3 [10–58] | 51.9 ± 17.5 [27.8–76.9] |
MDS-UPDRS – Part IV1 | 0.9 ± 2.7 [0–12] | 0.4 ± 0.6 [0–2] | 1.9 ± 4.5 [0–12] |
Hoehn & Yahr1,2 | 2 [1–4] | 2 [1–2] | 3 [2.5–4] |
More affected side (Left/Right) | 15/7 | 12/3 | 3/4 |